U
US BioTec Inc
OTC:USBC
US BioTec Inc
OTC:USBC
Price:
0.329
USD
-3.24%
Market Closed
Market Cap:
$127.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
U
|
US BioTec Inc
OTC:USBC
|
US |
|
S
|
Shandong Link Science and Technology Co Ltd
SZSE:001207
|
CN |
|
V
|
Voltage Metals Corp
CNSX:VOLT
|
CA |
|
Dare Bioscience Inc
NASDAQ:DARE
|
US |
|
Epwin Group PLC
LSE:EPWN
|
UK |
|
Jet2 PLC
LSE:JET2
|
UK |
|
BAIC BluePark New Energy Technology Co Ltd
SSE:600733
|
CN |
|
Marie Brizard Wine and Spirits SA
PAR:MBWS
|
FR |
|
Ginni Filaments Ltd
NSE:GINNIFILA
|
IN |
|
S
|
Sling Group Holdings Ltd
HKEX:8285
|
HK |
|
P
|
Permanent TSB Group Holdings PLC
ISEQ:PTSB
|
IE |
|
Valartis Group AG
SIX:VLRT
|
CH |
|
Z
|
Zhi Sheng Group Holdings Ltd
HKEX:8370
|
CN |
|
Berger Paints India Ltd
NSE:BERGEPAINT
|
IN |
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
CN |
|
Alamo Group Inc
NYSE:ALG
|
US |
|
Jiangsu Hengli Hydraulic Co Ltd
SSE:601100
|
CN |
|
Amlogic Shanghai Co Ltd
SSE:688099
|
CN |
|
Qingdao Port International Co Ltd
SSE:601298
|
CN |
|
Beijing Jingwei Hirain Technologies Co Inc
SSE:688326
|
CN |
|
P
|
PetroVietnam Fertilizer and Chemicals Corp
VN:DPM
|
VN |
|
G
|
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
|
CN |
|
Bobst Group SA
SIX:BOBNN
|
CH |
|
WuXi AppTec Co Ltd
SSE:603259
|
CN |
Balance Sheet
Balance Sheet Decomposition
US BioTec Inc
US BioTec Inc
Balance Sheet Decomposition is not available for
US BioTec Inc
US BioTec Inc
Balance Sheet
US BioTec Inc
US BioTec Inc
Currency:
| Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
4
|
12
|
13
|
8
|
3
|
9
|
|
| Cash Equivalents |
4
|
12
|
13
|
8
|
3
|
9
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
4
|
12
|
13
|
8
|
3
|
10
|
|
| PP&E Net |
0
|
1
|
1
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
115
|
|
| Total Assets |
5
N/A
|
13
+175%
|
14
+7%
|
8
-40%
|
4
-56%
|
125
+3 313%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
0
|
0
|
1
|
|
| Short-Term Debt |
4
|
9
|
2
|
3
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
6
|
11
|
4
|
5
|
5
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
24
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
12
+77%
|
4
-67%
|
5
+16%
|
6
+29%
|
28
+380%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
56
|
81
|
101
|
122
|
139
|
163
|
|
| Additional Paid In Capital |
54
|
83
|
111
|
126
|
136
|
260
|
|
| Total Equity |
2
N/A
|
1
N/A
|
10
+694%
|
4
-62%
|
2
N/A
|
97
N/A
|
|
| Total Liabilities & Equity |
5
N/A
|
13
+175%
|
14
+7%
|
8
-40%
|
4
-56%
|
125
+3 313%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
3
|
388
|
|
| Preferred Shares Outstanding |
3
|
3
|
3
|
3
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
